Skip to main content
2024 Guide to Patient Support Services

Jazz Pharmaceuticals

2024 PSS Guide

JazzCares Patient Support Services

Jazz Pharmaceuticals, through its JazzCares Patient Support Programs, offers access and reimbursement support and financial assistance options to patients who are prescribed its hematology/oncology drugs (Table).

Patient Support Programs

Patient support is available for Defitelio, Rylaze, Vyxeos, or Zepzelca, and a copay savings program is available for Zepzelca, Vyxeos, and Rylaze. JazzCares provides resources to help patients understand their insurance coverage and find information on sources of financial support.

JazzCares Patient Assistance Program

Patients with no insurance or those who are functionally uninsured or underinsured due to lack of coverage may be able to receive free medication through the JazzCares Patient Assistance Program.

Income and other criteria apply, and documented proof is required. For more information about eligibility and assistance, please contact a JazzCares specialist at 833-533-5299, Monday-Friday, 8 am-8 pm ET.

Application & Enrollment

JazzCares Program online enrollment for Vyxeos, Rylaze, and Zepzelca can be initiated through JazzCares.com or submitted by fax to 855-593-3955. Enrollment for Defitelio can be submitted by fax only. For more information, contact a JazzCares specialist at 833-533-5299 available Monday-Friday, 8 am-8 pm ET.

TABLE Jazz Pharmaceuticals Oncology/Supportive Care Drugs

Drugs
Indications
Patient support programs

Drug
Defitelio (defibrotide sodium)
Indications
Treatment of adult and pediatric patients with hepatic veno-occlusive disease associated with renal or pulmonary dysfunction after hematopoietic stem-cell transplantation
Patient support program

Drug
Rylaze (asparaginase erwinia chrysanthemi [recombinant]-rywn)
Indications
As a component of a multiagent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma in adult and pediatric patients 1 month or older who have developed hypersensitivity to Escherichia coli–derived asparaginase
Patient support program

Drug
Vyxeos (daunorubicin and cytarabine) liposome
Indications
Adults and pediatric patients 1 year and older with newly diagnosed therapy-related acute myeloid leukemia (AML) or AML with myelodysplasia-related changes
Patient support program

Drug
Zepzelca (lurbinectedin)
Indications
Treatment of adults with metastatic small-cell lung cancer with disease progression during or after platinum-based chemotherapy
Patient support program